Press kits

This information is intended for healthcare journalists, analysts and investors.

Pharmaceutical resources

ANORO™ ELLIPTA™

Arnuity™ Ellipta® & Incruse® Ellipta®

BREO® ELLIPTA™

NUCALA® (mepolizumab)

The IMPACT study: InforMing the PAthway of COPD Treatment

Trelegy Ellipta

Vaccine resources

General resources

Partnership to Help Communities Protect and Care for Children Impacted by Disasters